Friday 27th October 2000
|Text too small?|
Submarine venture snubs torpedos
Submarines Australasia is an imminent New Capital Market listing that plans to take over Submarine Adventures, a company starting up an underwater tourism venture in Milford Sound. Submarine Adventures recently took delivery of its first submarine, purpose-built at great cost and aims to be taking tourists out as early as next month. This sub holds only four paying passengers at a time and Ferdinand thinks the company could have done better for its money. Take this listing on specialist internet site Ships-for-sale.com, for example. It is offering a Whiskey class ex-naval submarine that can do 13.5 knots submerged, has a range of up to 24,000km, can dive to 200m and can carry 56 people. All this and more (such as functioning torpedo tubes) are available for a mere $US497,000 from the builders of the Kursk.
Giant takes an interest in Genesis
Biotech company Genesis Research & Development Corporation has done pretty well since listing in September. Its shares, issued at $6, are trading at around $6.60, valuing the company at around $162 million. This may not be a lot in world terms but Genesis also has some big friends. One of these is Immunex Corp of Seattle, US, which recently reported taking a 6.5% stake in Genesis and whose head of research sits on the board. Rather than the $6-7 that Genesis shares trade at, Immunex shares change hands on the Nasdaq at more than $100. Genesis has a $162 million market capitalisation but Immunex is worth more than $51 billion. Genesis doesn't expect to make a profit in the near future and hopes turnover will grow to $18.6 million by the end of 2001. Immunex made $105 million last year on revenue of $1.3 billion and is on track to half as much again this year. The involvement of a company like this in a little New Zealand outfit is a big vote of confidence but it also shows how far Genesis has to go to become globally competitive.
Michael Hill shares shine (a little)
Not often is a falling share price a cause for celebration but Michael Hill International is doing the best it can. In its latest annual report it notes its share price has gone from $3 at the end of June last year to $2.85 this year, a decline of 5%. That is rarely a reason for investors to break out the champagne but on a large graph the company points out the NZSE40 capital index moved from 2136 to 2030 in the same period, a decline of 5.2%. This outperformance of the market is even greater if one looks at the company's share price this week. At around $3.05, it has gained 2% since last June, while the poor old NZSE40 has declined 7.3%. Such news makes Ferdinand want to splash out on a diamond ring or two.
No comments yet
NZ dollar falls against Aussie after jobs data there
Sky CEO put on notice by chunky vote against salary share scheme
Unions gearing up to oppose 'market tests' on Fair Pay Agreements
Mandatory farm plans scorned as 'tick box' exercises
Kiwi dollar firms on weak US retail data, capped by rate-cut expectations
17th October 2019 Morning Report
SkyCity hoses down union claims over potential job losses
OPINION: Fair Payment Agreements and 'swallowing vomit' - the lot of the CTU
MARKET CLOSE: NZ shares gain; Restaurant Brands climbs on upbeat outlook
NZ dollar stalls after Bascand's rate cut comments